Andrew Hatton takes FreeHand at Prosurgics

Surgical robotics company Prosurgics, which supplies devices for laparoscopic surgery, has appointed Andrew Hatton as UK Country Manager. Andrew Hatton will be responsible...

Government curbs market in transplant organs

Patients paying for private transplant surgery using organs donated within the NHS will be banned from October. The Government has accepted the recommendations of...

Authorised generics here to stay, says Datamonitor

The number of authorised generics (AG) agreements will grow, in tandem with the increasing convergence between branded and generic drug companies, a new report...

Amgen makes denosumab deal

Amgen has formed a partnership with GlaxoSmithKline to commercialize denosumab for the treatment of postmenopausal osteoporosis in Europe and emerging markets. Denosumab is the...

RPSGB calls for fair prescribing abilities

The Royal Pharmaceutical Society of Great Britain (RPSGB) has called on the Prime Minister to introduce parity between nurses and pharmacists in the prescribing...

Portable blood banks for UK military

Compact human-portable blood storage units that maintain constant temperature are being supplied to the Ministry of Defence by a UK company. The...

Poor access to radiotherapy services

Over 30,000 patients with cancer in England each year are not receiving appropriate NHS radiotherapy, according to an audit-based study. The study, published...

Wales to screen for inherited cardiac risk

A screening programme to identify people at risk of heart attacks due to inherited high cholesterol levels will be introduced in Wales. The...

NICE tells US critics to ‘check their facts’

NICE has denied that it plays the role of a “death panel” in response to US criticism of the UK healthcare system. Right-wing opposition...

First wireless pacemaker implanted

The world's first wireless pacemaker has been implanted in a 61-year-old female patient in New York. The Accent RF pacemaker from St Jude Medical...

Latest articles

AveXis presents new data at 2019 EPNS Congress showing significant therapeutic benefit of Zolgensma

AveXis presents Zolgensma® data at EPNS

AveXis has presented new data on Zolgensma® at the 2019 European Paediatric Neurology Society (EPNS) Congress. The data continue to show the significant therapeutic...
image of a hospital and ambulance showing poor diabetes control costs the NHS £3bn in avoidable treatment

Poor diabetes control costs the NHS £3bn in avoidable treatment

New research finds that poor diabetes control costs the NHS £3bn in potentially avoidable hospital treatment in England. The findings, being presented at this year’s...
Takeda's Takhzyro ®▼ recommended on NHS for hereditary angiodema

Takeda’s Takhzyro®▼ recommended on NHS for hereditary angioedema

Takeda's Takhzyro®▼ recommended on NHS for hereditary angioedema (HAE) in a Final Appraisal Determination (FAD). The health technology appraisal body in England and Wales,...

Popular articles

AveXis presents new data at 2019 EPNS Congress showing significant therapeutic benefit of Zolgensma

Data-driven marketing in pharma: The future is here

Data-driven marketing in pharma, Pamela Walker and Joshua Hull explain why personalisation is the key to unlocking opportunity via pharma digital marketing. In pharma, ‘digital’...
Takeda's Takhzyro ®▼ recommended on NHS for hereditary angiodema

Takeda’s Takhzyro®▼ recommended on NHS for hereditary angioedema

Takeda's Takhzyro®▼ recommended on NHS for hereditary angioedema (HAE) in a Final Appraisal Determination (FAD). The health technology appraisal body in England and Wales,...
New report on access to cutting edge medicines

New report on access to cutting edge medicines

A new cross-party report is urging the life science community to work together and grasp the opportunity to speed up access to cutting-edge medicines...
Early signs of adult type 2 diabetes visible in 8 year olds

Early signs of adult type 2 diabetes visible in 8 year olds

Early signs of adult type 2 diabetes can be seen in children as young as 8 years old, decades before it is likely to...
SAnofi and Abbott partner to improve diabetes management with technology

Sanofi & Abbott in diabetes management partnership

Sanofi and Abbott have partnered to integrate glucose sensing and insulin delivery technologies to help to further simplify how people with diabetes manage their...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription